IL10 and melanoma: To summarize, reactive microglia, synaptic loss, diminished myelin, higher number of inflammatory monocytes in the brain, and elevated plasma IL-10 in melanoma-bearing mice indicate cancer burden-associated changes compared to healthy controls.